Bitcoin (btc)$83,681.00↑ 0.20%
Ethereum (eth)$2,681.54↓ 0.01%
Tether (usdt)$0.999574↓ 0.01%
BNB (bnb)$766.04↑ 1.06%
XRP (xrp)$1.49↓ 0.64%
USDC (usdc)$0.99979↓ 0.00%
Solana (sol)$117.84↓ 1.12%
TRON (trx)$0.337723↑ 0.87%
Figure Heloc (figr_heloc)$1.028↑ 2.39%
Zcash (zec)$1,406.00↓ 0.43%
Hyperliquid (hype)$90.92↑ 5.64%
Dogecoin (doge)$0.094053↓ 0.19%
Chainlink (link)$14.32↓ 2.66%
Monero (xmr)$539.95↓ 0.93%
WhiteBIT Coin (wbt)$83.55↑ 0.11%
Bitcoin (btc)$83,681.00↑ 0.20%
Ethereum (eth)$2,681.54↓ 0.01%
Tether (usdt)$0.999574↓ 0.01%
BNB (bnb)$766.04↑ 1.06%
XRP (xrp)$1.49↓ 0.64%
USDC (usdc)$0.99979↓ 0.00%
Solana (sol)$117.84↓ 1.12%
TRON (trx)$0.337723↑ 0.87%
Figure Heloc (figr_heloc)$1.028↑ 2.39%
Zcash (zec)$1,406.00↓ 0.43%
Hyperliquid (hype)$90.92↑ 5.64%
Dogecoin (doge)$0.094053↓ 0.19%
Chainlink (link)$14.32↓ 2.66%
Monero (xmr)$539.95↓ 0.93%
WhiteBIT Coin (wbt)$83.55↑ 0.11%

Beiersdorf Partners with Vincere Biosciences to Develop Cell-Rejuvenating Skincare – Draper Decentralized – 6.04.25

Published June 4, 2025

Beiersdorf has entered a strategic partnership with Cambridge-based Vincere Biosciences to co-develop skincare solutions targeting cellular aging. The collaboration focuses on mitophagy, combining Beiersdorf’s expertise in coenzyme Q10 with Vincere’s research on the USP30 enzyme.